E-LIB Suche - Ergebnisse für: Capdevila, O.

1

Predictive Factors of the Use of Rituximab and Belimumab in..:

Capdevila, O. ; Mitjavila, F. ; Espinosa, G....
Medicina. 59 (2023) 8 - p. 1362 , 2023

Link: https://doi.org/10.3390/..

2

Pragmatic, open-label, single-center, randomized, phase II ..:

Solanich, X. ; Antolí, A. ; Padullés, N....
Contemporary Clinical Trials Communications. 21 (2021) - p. 100716 , 2021

Link: https://doi.org/10.1016/..

3

Infections in newly diagnosed Spanish patients with systemi..:

González-Echavarri, C ; Capdevila, O ; Espinosa, G...
Lupus. 27 (2018) 14 - p. 2253-2261 , 2018

Link: https://doi.org/10.1177/..

4

Bacteremic Pneumococcal Cellulitis Compared with Bacteremic..:

Capdevila, O. ; Grau, I. ; Vadillo, M...
European Journal of Clinical Microbiology & Infectious Diseases. 22 (2003) 6 - p. 337-341 , 2003

Link: https://doi.org/10.1007/..

5

6. Bright light therapy in a chronobiological disorder:

Sans Capdevila, O. ; Méndez García, M. ; Abril Villalba, B...
Clinical Neurophysiology. 120 (2009) 4 - p. e134 , 2009

Link: https://doi.org/10.1016/..

6

Predictive Factors of the Use of Rituximab and Belimumab in..:

Capdevila, O ; Mitjavila, F ; Espinosa, G...
Reproducció del document publicat a: https://doi.org/10.3390/medicina59081362. , 2023

Link: http://hdl.handle.net/24..

7

Caracterització d'aïllats de Botrytis Cinerea pers. resiste..:

Capdevila, O ; García, S ; Navarro Alonso, Albert.. , 2001

Link: http://hdl.handle.net/20..

8

Caracterització d'aïllats de Botrytis Cinerea pers. resiste..:

Capdevila, O ; García, S ; Navarro Alonso, Albert..
Capdevila, O. [et al.]. Caracterització d'aïllats de Botrytis Cinerea pers. resistents a fungicides en l'àrea de producció hortícola del litoral barceloní. "Arxius de l'ESAB", 2001, vol. 5, p. 13-20.. , 2001

Link: http://hdl.handle.net/20..

9

Prevalence of sleep-related breathing disorders in children..:

Vázquez-Casas, I. ; Sans-Capdevila, O. ; Moncunill-Mira, J..
Journal of Clinical and Experimental Dentistry. , 2020

Link: https://doi.org/10.4317/..

10

Insomnia in young children with angelman syndrome: characte..:

Moraleda-Cibrián, M. ; Arasanz-Armengol, M. ; Delgadillo-Chilavert, V....
Sleep Medicine. 40 (2017) - p. e230 , 2017

Link: https://doi.org/10.1016/..

11

Predictive Factors of the Use of Rituximab and Belimumab in..:

O. Capdevila ; F. Mitjavila ; G. Espinosa...
Hematology and Immunology. , 2023

Link: https://doi.org/10.3390/..

12

Predictive Factors of the Use of Rituximab and Belimumab in..:

O. Capdevila ; F. Mitjavila ; G. Espinosa...
https://www.mdpi.com/1648-9144/59/8/1362. , 2023

Link: https://doi.org/10.3390/..

13

Pragmatic, open-label, single-center, randomized, phase II ..:

X. Solanich ; A. Antolí ; N. Padullés...
http://www.sciencedirect.com/science/article/pii/S2451865421000181. , 2021

Link: https://doi.org/10.1016/..

14

Cabozantinib for previously treated radioiodine‐refractory ..:

Brose, Marcia S. ; Robinson, Bruce G. ; Sherman, Steven I....
Cancer. 128 (2022) 24 - p. 4203-4212 , 2022

Link: https://doi.org/10.1002/..

15

Libretto-531: A Phase III Study of Selpercatinib in Multiki..:

Wirth, Lori J ; Brose, Marcia S ; Elisei, Rossella...
Future Oncology. 18 (2022) 28 - p. 3143-3150 , 2022

Link: https://doi.org/10.2217/..